Coegin Pharma
4.5
SEK
+8.96 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
+8.96%
+0.9%
+16.88%
+18.73%
-15.09%
+47.54%
-83.84%
+311.05%
-85.85%
Coegin Pharma is a Swedish biotechnology company with dermacosmetic projects for hair growth and skin pigmentation, as well as drug candidates for the treatment of heart attacks and leukemia. What the projects have in common is that they are based on patented technology platforms and collaborations with researchers and academics internationally. Coegin Pharma has its headquarters in Lund.
Read moreMarket cap
111.95M SEK
Turnover
296.11K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
22.5
2025
Interim report Q1'25
22.5
2025
General meeting '25
21.8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
Coegin Pharma AB (publ) publishes its year-end report for 2024
Groundbreaking cancer treatment research published in "Nature Communications"
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools